J. Berding, J. A. van Paridon, V. H. S. van Rixel, E. Bouwman
FULL PAPER
haloalkane in dry THF or 1,4-dioxane was placed under an argon
atmosphere and stirred at 80 or 100 °C, respectively, for 24 h. When
1080 (m), 828 (m), 785 (m), 747 (s), 697 (s), 600 (s), 484 (m) cm–1.
C14H13IN2 (336.18): calcd. C 50.02, H 3.90, N 8.33; found C 50.11,
using iodomethane as alkylating agent, the reaction mixture was H 3.92, N 8.39. MS (ESI): m/z (%) = 209 (100) [[M – I]+].
stirred at room temperature. The off-white precipitate was collected
General Procedure for the Synthesis of Nickel Complexes: A mixture
by filtration and recrystallized from methanol/diethyl ether to yield
of (benz)imidazolium halide, 0.5 equiv. anhydrous NiII acetate and
a white solid, which was dried in vacuo.
about 50% of the combined weight of the two reagents of the corre-
sponding tetrabutylammonium halide was dried in vacuo at 60 °C
for 1 h. The temperature was then raised to 130 °C (bromide salts)
or 155 °C (iodide salts) and kept at this temperature in vacuo for
several hours. After cooling, water was added and the mixture was
triturated thoroughly. After isolation of the crude product by fil-
tration, the pure compound was obtained either by repeated wash-
ing of a dichloromethane solution of the crude product with water,
evaporation of the solvent and precipitation with diethyl ether
(compounds 3a,b,e and 4b), or by recrystallization from hot DMF
(compounds 4c,d,e), and were isolated as red-orange to purple sol-
ids.
N-Methyl-NЈ-phenylimidazolium Iodide (1e): The synthesis was per-
formed according to the general procedure, starting from 2.16 g of
N-phenylimidazole (15 mmol) and 2.42 g of iodomethane
(17 mmol) in 20 mL of THF; yield 4.21 g (98%). 1H NMR
(300 MHz, 300 K, [D6]DMSO): δ = 9.80 (s, 1 H, NCHN), 8.31 (s,
1 H, NCH), 7.98 (s, 1 H, NCH), 7.79 (m, 2 H, Ar-H), 7.68–7.58
(m, 3 H, Ar–H), 3.96 (s, 3 H, NCH3) ppm. 13C NMR (75 MHz,
300 K, [D6]DMSO): δ = 137.2 (NCHN), 136.0 (Cq), 131.5 (CAr),
131.0 (CAr), 125.7 (NCH), 123.1 (CAr), 122.2 (NCH), 37.6 (NCH3)
ppm. IR (neat): ν = 3447 (m), 3371 (m), 3094 (m), 3029 (m), 1599
˜
(w), 1576 (m), 1553 (m), 1496 (m), 1423 (w), 1222 (m), 1068 (m),
813 (w), 758 (s), 682 (s), 611 (s) cm–1. C10H11IN2·0.5H2O (295.12):
calcd. C 40.70, H 4.10, N 9.49; found C 40.69, H 4.01, N 9.48. MS
(ESI): m/z (%) = 159 (100) [[M – I]+].
Bis(N,NЈ-dimethylimidazol-2-ylidene)diiodidonickel(II) (3a): Follow-
ing the general procedure, the complex was obtained from 1.12 g of
imidazolium iodide 1a (5.0 mmol) and 0.44 g of nickel(II) acetate
(2.5 mmol), without the addition of tetrabutylammonium iodide,
at 155 °C; yield 0.69 g (55%). NMR spectra are identical to those
reported in the literature.[22]
N-Methyl-NЈ-isopropylbenzimidazolium Bromide (2b): Following
the general procedure, the compound was obtained from 1.06 g of
N-methylbenzimidazole (8.0 mmol) and 1.23 g of 2-bromopropane
(10.0 mmol) in 30 mL of 1,4-dioxane and isolated as a white solid;
yield 1.41 g (69). 1H NMR (300 MHz, 300 K, [D6]DMSO): δ = 9.93
(s, 1 H, NCHN), 8.12 (m, 1 H, Ar–H), 8.03 (m, 1 H, Ar–H), 7.69
(m, 2 H, Ar–H), 5.06 (sept, J = 7 Hz, 1 H, NCH), 4.07 (s, 3 H,
NCH3), 1.60 (d, J = 7 Hz, 6 H, CH3) ppm. 13C NMR (75 MHz,
300 K, [D6]DMSO): δ = 141.1 (NCHN), 132.0 (Cq), 130.3 (Cq),
126.4 (CBim), 126.3 (CBim), 113.8 (CBim), 113.6 (CBim), 50.3 (NCH3),
Bis(N-ethyl-NЈ-methylimidazol-2-ylidene)diiodidonickel(II)
(3b):
Following the general procedure, 1.19 g of imidazolium iodide 1b
(5.0 mmol) and 0.44 g of nickel(II) acetate (2.5 mmol) were reacted
in 0.8 g of tetrabutylammonium iodide at 155 °C; yield 0.47 g
(35%). 1H NMR (300 MHz, 300 K, CDCl3): δ = 6.77 (m, 4 H,
NCH), 4.84 (2ϫq, J = 7 Hz, 4 H, NCH2), 4.26 (s, 6 H, NCH3),
1.69 (2ϫt, J = 7 Hz, 6 H, CH3) ppm. 13C NMR (75 MHz, 300 K,
CDCl3): δ = 123.2 (NCH), 120.5 (NCH), 45.6 (NCH2), 37.9
33.2 (NCH), 21.6 (CH ) ppm. IR (neat): ν = 3080 (w), 2978 (w),
˜
3
1564 (m), 1456 (m), 1436 (m), 1349 (m), 1262 (m), 1216 (m), 1100
(m), 1016 (w), 830 (w), 759 (s), 615 (m), 552 (m) cm–1. C11H15BrN2
(255.16): calcd. C 51.78, H 5.93, N 10.98; found C 51.98, H 6.15,
N 10.85. MS (ESI): m/z (%) = 175 (100) [[M – Br]+], 133 [[M –
Br – C3H7 + H]+].
(NCH ), 15.2 (CH ) ppm. IR (neat): ν = 3098 (w), 2972 (w), 1558
˜
3
3
(w), 1455 (m), 1401 (m), 1256 (m), 1219 (s), 1085 (m), 954 (m), 796
(m), 732 (s), 697 (s) cm–1. C12H20I2N4Ni (532.84): calcd. C 27.05,
H 3.78, N 10.52; found C 27.27, H 3.49, N 10.44. MS (ESI): m/z
(%) = 446 (100) [[M – I + MeCN]+].
N-Methyl-NЈ-isopropylbenzimidazolium Iodide (2c): According to
the general synthesis, 2.64 g of N-methylbenzimidazole (20 mmol)
was treated with 4.25 g of 2-iodopropane (25 mmol) in 25 mL of
THF. The compound was obtained as a white solid; yield 3.87 g
Bis(N-methyl-NЈ-phenylimidazol-2-ylidene)diiodidonickel(II) (3e):
Following the general procedure, the compounds was obtained
starting from 2.28 g of imidazolium salt 1e (8.0 mmol) and 0.71 g
of nickel(II) acetate (4.0 mmol) in 1.5 g of tetrabutylammonium
1
1
(64%). H NMR (300 MHz, 300 K, [D6]DMSO): δ = 9.81 (s, 1 H,
iodide at 155 °C; yield 0.73 g (29%). H NMR (300 MHz, 300 K,
NCHN), 8.12 (m, 1 H, Ar–H), 8.02 (m, 1 H, Ar–H), 7.69 (m, 2 H,
Ar–H), 5.05 (sept, J = 7 Hz, 1 H, NCH), 4.06 (s, 3 H, NCH3), 1.60
(d, J = 7 Hz, 6 H, CH3) ppm. 13C NMR (75 MHz, 300 K, [D6]-
DMSO): δ = 141.2 (NCHN), 131.9 (Cq), 130.3 (Cq), 126.4 (CBim),
126.3 (CBim), 113.7 (CBim), 113.6 (CBim), 50.3 (NCH3), 33.3 (NCH),
CDCl3): δ = 8.28 (d, J = 8 Hz, 4 H, Ar-H), 7.61 (t, J = 8 Hz, 4 H,
Ar-H), 7.49 (t, J = 8 Hz, 2 H, Ar-H), 7.00 (d, J = 2 Hz, 2 H, NCH),
6.84 (d, J = 2 Hz, 2 H, NCH), 4.01 (s, 6 H, NCH3) ppm. 13C NMR
(75 MHz, 300 K, CDCl3): δ = 174.7 (Ni-C), 140.8 (Cq), 128.8 (CAr),
128.1 (CAr), 126.4 (CAr), 123.6 (NCH), 122.6 (NCH), 38.2 (NCH3)
21.6 (CH ) ppm. IR (neat): ν = 3022 (w), 2979 (w), 1610 (w), 1567
˜
ppm. IR (neat): ν = 3129 (w), 1598 (w), 1497 (s), 1444 (m), 1403
˜
3
(m), 1456 (m), 1431 (m), 1352 (w), 1260 (m), 1215 (m), 1135 (m),
760 (s), 618 (m), 603 (m), 425 (m) cm–1. C11H15IN2 (302.16): calcd.
C 43.73, H 5.00, N 9.27; found C 43.88, H 5.39, N 9.37. MS (ESI):
m/z (%) = 175 (100) [[M – I]+], 133 [[M – I – C3H7 + H]+].
(w), 1229 (m), 1069 (m), 915 (m), 759 (m), 724 (m), 690 (s), 623
(m), 547 (m) cm–1. C20H20I2N4Ni (628.93): calcd. C 38.20, H 3.21,
N 8.91; found C 38.23, H 3.00, N 8.86. MS (ESI): m/z (%) = 542
[[M – I + MeCN]+], 501 (100) [[M – I]+], 228 [[M – 2I +
MeCN]2+].
N-Methyl-NЈ-phenylbenzimidazolium Iodide (2d): Following the ge-
neral procedure, the compound was obtained as a white solid from
1.17 g of N-phenylbenzimidazole (6.0 mmol) and 0.85 g of iodo-
methane (7.0 mmol) in 15 mL of THF; yield 1.67 g (83%). 1H
Bis(N,NЈ-dibenzylimidazol-2-ylidene)dibromidonickel(II) (3f):
A
mixture of 0.23 g of ligand precursor 1f (1.0 mmol) and 0.14 g of
silver(I) oxide (0.5 mmol) in 10 mL of dichloromethane was stirred
NMR (300 MHz, 300 K, [D6]DMSO): δ = 10.12 (s, 1 H, NCHN), in the absence of light at room temperature for 2 h. The resulting
8.15 (m, 1 H, Ar-H), 7.87–7.68 (m, 8 H, Ar–H), 4.17 (s, 3 H, solution was filtered with the aid of a membrane filter and added
NCH3) ppm. 13C NMR (75 MHz, 300 K, [D6]DMSO): δ = 143.1 to a solution of 0.34 g of Ni(PPh3)2Br2 (0.5 mmol) in dichlorometh-
(NCHN), 133.1 (Cq), 131.8 (Cq), 130.8 (Cq), 130.4 (2ϫCPh), 127.4 ane. A rapid color change from green to red occurred and stirring
(CBim), 126.9 (CBim), 125.1 (CPh), 113.9 (CBim), 113.3 (CBim), 33.5
was continued for 30 min. The off-white precipitate that had
(NCH ) ppm. IR (neat): ν = 3021 (w), 1563 (m), 1557 (s), 1487 formed was removed by filtration to give an orange solution, which
˜
3
(m), 1424 (w), 1308 (w), 1263 (m), 1239 (m), 1161 (m), 1133 (m),
was concentrated in vacuo until a red solid started to precipitate.
2456
www.eurjic.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2011, 2450–2458